Evidence map›Paper›PMID 33708200›Full record

ArticleFrontiers in immunology2021

Correlation Between Immune Lymphoid Cells and Plasmacytoid Dendritic Cells in Human Colon Cancer.

Jing Wu, Hang Cheng, Helei Wang, Guoxia Zang, Lingli Qi, Xinping Lv, Chunyan Liu, Shan Zhu, Mingyou Zhang, Jiuwei Cui and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Immuno-oncology-microbiome axis of gastrointestinal malignancy.World journal of gastrointestinal oncology · 2023
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Jing WuInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Hang ChengInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Helei WangInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Guoxia ZangInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Lingli QiInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Xinping LvInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Chunyan LiuInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Shan ZhuInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Mingyou ZhangDepartment of Cardiovascular Center, The First Hospital, Jilin University, Changchun, China.
Jiuwei CuiCancer Center, The First Hospital, Jilin University, Changchun, China.
Hideki UenoDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Yong-Jun LiuDepartment of Research and Development of Sanofi, Cambridge, MA, United States.
Jian SuoDepartment of Stomach Colorectal Anal Surgery, The First Hospital, Jilin University, Changchun, China.
Jingtao ChenInstitute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
First Hospital of Jilin University · CNJilin University · CNIcahn School of Medicine at Mount Sinai · USSanofi (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Innate lymphoid cells (ILCs), so far studied mostly in mouse models, are important tissue-resident innate immune cells that play important roles in the colorectal cancer microenvironment and maintain mucosal tissue homeostasis. Plasmacytoid dendritic cells (pDCs) present complexity in various tumor types and are correlated with poor prognosis. pDCs can promote HIV-1-induced group 3 ILC (ILC3) depletion through the CD95 pathway. However, the role of ILC3s in human colon cancer and their correlation with other immune cells, especially pDCs, remain unclear. Methods: We characterized ILCs and pDCs in the tumor microenvironment of 58 colon cancer patients by flow cytometry and selected three patients for RNA sequencing. Results: ILC3s were negatively correlated, and pDCs were positively correlated, with cancer pathological stage. There was a negative correlation between the numbers of ILC3s and pDCs in tumor tissues. RNA sequencing confirmed the correlations between ILC3s and pDCs and highlighted the potential function of many ILC- and pDC-associated differentially expressed genes in the regulation of tumor immunity. pDCs can induce apoptosis of ILC3s through the CD95 pathway in the tumor-like microenvironment. Conclusions: One of the interactions between ILC3s and pDCs is

Indexed as

AgedColonic NeoplasmsDendritic Cellsfas ReceptorFemaleFlow CytometryHumansLymphocytesMaleMiddle AgedSignal TransductionTumor MicroenvironmentFAS protein, humanfas Receptorapoptosiscolon cancerILCILC3pDCRNA-Seq

Identifiers

PMID33708200
PMCPMC7940519
OpenAlexW3120078150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.